BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen X, Yu B, Chen M. Circulating levels of neuropeptide proenkephalin A predict outcome in patients with aneurysmal subarachnoid hemorrhage. Peptides 2014;56:111-5. [DOI: 10.1016/j.peptides.2014.04.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Shafieesabet A, Doehner W. Proenkephalin A as Potential Prognostic Biomarker in Acute Ischemic Stroke. Clin Appl Thromb Hemost 2020;26:1076029620945037. [PMID: 32731754 DOI: 10.1177/1076029620945037] [Reference Citation Analysis]
2 Yang X, An H, Zhang J. Neuropeptide proenkephalin A is associated with in-hospital mortality in patients with acute intracerebral hemorrhage. Peptides 2014;58:47-51. [DOI: 10.1016/j.peptides.2014.06.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
3 Thorgeirsdóttir B, Levin H, Spångfors M, Annborn M, Cronberg T, Nielsen N, Lybeck A, Friberg H, Frigyesi A. Plasma proenkephalin A 119-159 and dipeptidyl peptidase 3 on admission after cardiac arrest help predict long-term neurological outcome. Resuscitation 2021;163:108-15. [PMID: 33930500 DOI: 10.1016/j.resuscitation.2021.04.021] [Reference Citation Analysis]
4 Jun Q, Luo W. Early-stage serum Stanniocalcin 1 as a predictor of outcome in patients with aneurysmal subarachnoid hemorrhage. Medicine (Baltimore) 2021;100:e28222. [PMID: 34941085 DOI: 10.1097/MD.0000000000028222] [Reference Citation Analysis]
5 Yokoyama K, Maruwaka M, Yoshikawa K, Araki Y, Okamoto S, Sumitomo M, Kawamura A, Sakamoto Y, Shimizu K, Izumi T, Wakabayashi T. Elevation of Proenkephalin 143–183 in Cerebrospinal Fluid in Moyamoya Disease. World Neurosurgery 2018;109:e446-59. [DOI: 10.1016/j.wneu.2017.09.204] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
6 Gandolfi M, Smania N, Vella A, Picelli A, Chirumbolo S. Assessed and Emerging Biomarkers in Stroke and Training-Mediated Stroke Recovery: State of the Art. Neural Plast 2017;2017:1389475. [PMID: 28373915 DOI: 10.1155/2017/1389475] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
7 Gruber P, Fluri F, Schweizer J, Luft A, Müller B, Christ-Crain M, Katan M. Proenkephalin A Adds No Incremental Prognostic Value After Acute Ischemic Stroke. Clin Appl Thromb Hemost 2020;26:1076029619895318. [PMID: 31973568 DOI: 10.1177/1076029619895318] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Frigyesi A, Boström L, Lengquist M, Johnsson P, Lundberg OHM, Spångfors M, Annborn M, Cronberg T, Nielsen N, Levin H, Friberg H. Plasma proenkephalin A 119-159 on intensive care unit admission is a predictor of organ failure and 30-day mortality. Intensive Care Med Exp 2021;9:36. [PMID: 34278538 DOI: 10.1186/s40635-021-00396-6] [Reference Citation Analysis]
9 Bodnar RJ. Endogenous opiates and behavior: 2014. Peptides 2016;75:18-70. [PMID: 26551874 DOI: 10.1016/j.peptides.2015.10.009] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 7.6] [Reference Citation Analysis]
10 Gao JB, Tang WD, Wang X, Shen J. Prognostic value of neuropeptide proenkephalin A in patients with severe traumatic brain injury. Peptides 2014;58:42-6. [PMID: 24937655 DOI: 10.1016/j.peptides.2014.06.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]